MODIFICATION OF CARDIOINTEGRAM/CARDIOINTEGRAPH— 510(k) K863153

Substantially Equivalent

Ocg Technology, Inc.

FDA 510(k) clearance K863153 for MODIFICATION OF CARDIOINTEGRAM/CARDIOINTEGRAPH, Substantially Equivalent on 1987-01-06. Applicant: Ocg Technology, Inc..

Clearance details

Applicant
Ocg Technology, Inc.
Product code
Code DXG
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Farmingdale, NY, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.